Saurabh Zanwar
@ZanwarSaurabh
Followers
1K
Following
4K
Statuses
891
All things Myeloma, Amyloid and Waldenstrom @MayoHemeOnc | Former @MAYOMN_IMRES and @TataMemorial | @ManUtd and @bcci| Tweets are my own|
Minnesota, USA
Joined September 2016
RT @nihardesai89: 🎉 Out now in @BloodAdvances 🙌🏽 Our work from @pmcancercentre looking at PTCy in matched sibling donor allogeneic transpl…
0
20
0
RT @RomanosSP: Check out our new study using single-cell RNA-seq to characterize immune dysregulation and identify molecular subtypes in pa…
0
5
0
RT @AlGarfall: Important observations by our group @PennCancer led by @MatthewHoMD on non-tuberculous mycobacterial infections in #mmsm pat…
0
2
0
RT @MarcusVPinto: Amyloid neuropathies are treatable and should not be missed. @gabifpucci and I updated the @neudrawlogy amyloid neuropath…
0
83
0
RT @SantiagoThibaud: We will explore potential implications of these gene changes for MM risk, treatment decisions and family health 🔗to o…
0
2
0
RT @Taxkourel: Now accepting applications for the #Amyloidosis Fellowship @MayoAmyloid. Supported by @Amyloidosis_ARC , with the goal of tr…
0
9
0
RT @VincentRK: Just out: An outstanding Review of Essential Thrombocythemia in @JAMA_current — it covers all aspects of this disease. Aut…
0
16
0
@MayoMN_IMRES @CaThompsonMD Congratulations everyone! @JithmaA @AntoineNSaliba no surprises seeing your names here! đź‘Źđź‘Ź
0
0
4
0
0
2
1
0
1
@hhashmi87 The durability of responses is so encouraging to see in EMD patients that do respond! An ORR of 60% relatively comparable to that with CART for EMDs. Would be curious to see how this holds up in prior IET exposed patients or vice versa how CART fares after TnT.
0
0
1
0
0
1
1
0
1
RT @OncoThor: Raise your hand if you are surprised about this... I have never been as unsurprised by the results of a research paper... h…
0
2
0
@rajshekharucms @bdermanmd Yes, was noted in the original report as well. Challenge is whether those ORRs are sustained or not in EMD
0
0
0
1
0
1
@AlGarfall Excellent thread and very valid points. Completely agree! Like many others, ASCT is yet another effective Rx option. But unlike others, comes with an expiry date! Use it or lose it. Might be biased, but majority of the exceptional responders that I have seen received an ASCT.
1
0
1